Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-09-13
1997-10-21
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 14, 530330, 530329, 530328, A61K 3808, C07K 700
Patent
active
056796420
ABSTRACT:
Peptide-chelator conjugates are provided that when labelled with a traceable metal are useful for diagnostic imaging of sites of inflammation. The peptide component is an antagonist of the naturally occurring tetrapeptide tuftsin while the chelator component serves as a labelling site for metals, in particular radionuclide metals such as technetium-99m.
REFERENCES:
patent: 4390528 (1983-06-01), Najjar
patent: 4729848 (1988-03-01), Vincent
patent: 4914226 (1990-04-01), Di Trapani
patent: 4957736 (1990-09-01), Nencioni
patent: 4965250 (1990-10-01), Vincent
patent: 4965392 (1990-10-01), Fritzberg
patent: 4986979 (1991-01-01), Morgan
patent: 5021567 (1991-06-01), Johnson
patent: 5028593 (1991-07-01), Nishioka
patent: 5043423 (1991-08-01), Viscomi
patent: 5047400 (1991-09-01), Vincent
patent: 5071965 (1991-12-01), Dunn
patent: 5082930 (1992-01-01), Nicolotti
patent: 5091514 (1992-02-01), Fritzberg
patent: 5112594 (1992-05-01), Woulfe
patent: 5112595 (1992-05-01), Woulfe
patent: 5175257 (1992-12-01), Kasina
patent: 5175343 (1992-12-01), Fritzberg
patent: 5187264 (1993-02-01), Verbruggen
patent: 5196515 (1993-03-01), Lever
patent: 5202109 (1993-04-01), Fritzberg
patent: 5202451 (1993-04-01), Fritzberg
patent: 5220000 (1993-06-01), Theodoropulos
patent: 5248764 (1993-09-01), Flanagan
patent: 5433816 (1995-07-01), Zamora et al.
patent: 5480970 (1996-01-01), Pollak et al.
Beherucci et al., "Agents Actions", Special Conf. Issue (1992), pp. C115-C117.
Siemion et al., "Int. J. Peptide Prot. Res.", vol. 35, (1990) pp. 428-433.
Bump et al., "Isolation and Subunit Composition of Tuftsin Receptor", Proc. Natl. Acad. Sci., U.S.A., vol. 83, No. 19, (1986), pp. 7187-7191.
Babich et al., "Technetium-99m-labeled Chemotactic Peptides", J Nucl Med., vol. 34, No. 2176, (1993).
Clarke et al., "Medical Diagnostic Imaging with Complexes of 99mTc", Coordination Chemistry Reviews, vol. 78, No. 253, (1987).
Dewanjee et al., "The Chemistry of .sup.99m T-labeled Radiopharmaceuticals", Seminars in Nuclear Medicine, vol. XX, No. 1, (1990) pp. 5-27.
Fischman et al., "Imaging Focal Sites of Bacterial Infection in Rats with Indium-111-labeled Chemotactic Peptide Analogs", J Nuclear Med., vol. 32, No. 3, (1991) pp. 483.
Fischman et al., "In Vivo Bioactivity and Biodistribution of Chemotactic Peptide Analogs in Nonhuman Primates", J Nuclear Med, vol. 23, No. 2134, (1993).
Fridkin et al., "Tuftsin, Thr-Lys-Pro-Arg", Mol Cell Biochem, vol. 41, No. 73, (1981).
Miller, "Synthetic Peptides Come of Age", J Nuclear Med, vol. 34, No. 11, (1985), pp. 15N.
McAfee et al., "Update on Radiopharmaceuticals for Medical Imagining",Radiology, vol. 171, No. 59 (1989).
Showell et al., "The Structure-Activity Relations of Synthetic Peptides as Chemotactic Factors and Inducers of Lysosomal Enzyme Secretion for Neutrophils", J Exp. Med, vol. 143, No. 1154, (1976).
Paik et al, "The Labeling of High Affinity sites of Antibodies with 99m-Tc", Int. J Nuclear Med Biol, vol. 12, No. 1, (1985), p. 3.
Konopinska et al., "Elongated Tuftsin Analogues--Synthesis and Biological Investigation", vol. 419, Database Cancerlit, Abstract No. 384993, pp. 35-43.
Florentin et al., "Immunophamacological Properties of Tuftsin and of Some Analogues", Database Embase, Elsevier Science Publishers, Abstract No. 5599439, pp. 177-191.
Goodbody Anne
Pollak Alfred
Hutzell Paula K.
Prickril Benet
Resolution Pharmaceuticals Inc.
LandOfFree
Peptide-chelator conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide-chelator conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-chelator conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1006729